Trial
NCT04778410
Study of Magrolimab Combinations in Participants With Myeloid Malignancies
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Gilead Sciences
Collaborators
—
Condition
Myeloid Malignancies
Intervention
Magrolimab
Why stopped
Sponsor decision to terminate the study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-03-20